Ipsen
Manufacturing · France · 5K - 10K Employees
View Company Info for Free
Overview
Headquarters
65 Quai Georges Gorse, Boulogne-Billanco...Phone Number
+33 158335000Website
www.ipsen.comRevenue
$4.4 BillionStock Symbol
IPNIndustry
ZI Rank: 2
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
11
1
2
2
2
2
About Ipsen
Founded in 1929 and headquartered in Boulogne, France, Ipsen Pharma is a global biopharmaceutical group focused on specialty care. The Group develops and commercializes medicines in therapeutic areas including oncology, neuroscience, and rare diseases.Explore more
Ipsen Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Ipsen your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Ipsen
Click to see if Ipsen had a recent Job posting/layoffs
Earning: See what the market has to say on Ipsen recently announced quarterly report
Check if Ipsen has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Ipsen has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Ipsen launches new products
Ipsen, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Ipsen is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined Ipsen as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Ipsen is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Ipsen is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Ipsen.
Ipsen Tech Stack
A closer look at the technologies used by Ipsen
See more technologies
Most Recent Scoops
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Open Position
Open Position
Open Position
Open Position
Ipsen News & Media
Dysport® is the first botulinum toxin to achieve positive topline Phase III results in both episodic and chronic migraine.
PARIS, FRANCE – 9 JULY 2026 – Ipsen (Euronext: IPN; ADR: IPSEY) today announced positive topline results from its Phase III BEOND migraine program evaluating Dysport® (abobotulinumtoxinA) for the prevention of episodic (E-BEOND) and chronic migraine (C-BEOND) in adults. Both the E-BEOND and C-BEOND trials met their primary endpoints, a reduction in monthly migraine days versus placebo.Ipsen - Half year statement - 2026 06 30
Half-year statement of the liquidity agreement between IPSEN SA and NATIXIS ODDO BHFIPSEN - Buy-back programme - Art 5 of MAR - Week 26- 2026
Aggregated presentation by day and by marketIpsen bolsters rare disease pipeline in €700m Memo takeover
This is Ipsen’s second acquisition this week, following its blockbuster Kartos buyout on 29 June.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Ipsen
Sign Up For FreeTo access detailed company insights
Founded in 1929 and headquartered in Boulogne, France, Ipsen Pharma is a global biopharmaceutical group focused on specialty care. The Group develops and commercializes medicines in therapeutic areas including oncology, neuroscience, and rare diseases.... Read More
